Product Information
METHAZOLAMIDE 25 MG TABLET is a generic product labeled by Oceanside Pharmaceuticals, priced at $0.9515 per EA under NDC 68682002210. Its NADAC has been published 249 times since Dec 30, 2020.
FDA first approved this application on Oct 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the methazolamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682002210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
METHAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207438FDA Approved
10/5/2018
TE Code
AB
On Market Since
10/2/2020
Price Statistics
The NADAC for METHAZOLAMIDE 25 MG TABLET has been published 249 times since Dec 30, 2020, and over the history we have for it it has declined 58.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9515 per EA |
|---|---|
| All-time high | $2.2837 (Mar 10, 2021) |
| All-time low | $0.7422 (May 21, 2025) |
| Median price | $1.3174 |
| Average price | $1.4782 |
| Largest weekly change | -46.6% (Apr 19, 2023) |
| Weeks tracked | 249 |
| Tracking since | Dec 30, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-19.7%
5Y
-54.3%
All
-58.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methazolamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHAZOLAMIDE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHAZOLAMIDE 25 MG TABLET, manufactured by Oceanside Pharmaceuticals, is $0.9515 per EA (NDC 68682002210), effective Oct 1, 2025.
How has the price of METHAZOLAMIDE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHAZOLAMIDE 25 MG TABLET has declined 58.3%. It has been tracked across 249 weekly CMS publications since Dec 30, 2020.
What are the highest and lowest recorded NADAC prices for METHAZOLAMIDE 25 MG TABLET?
Since Dec 30, 2020, the NADAC for METHAZOLAMIDE 25 MG TABLET has ranged from a low of $0.7422 (May 21, 2025) to a high of $2.2837 (Mar 10, 2021), with a median of $1.3174 per EA.
Are there cheaper alternatives to METHAZOLAMIDE 25 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHAZOLAMIDE 25 MG TABLET, is $0.6275 per EA — about 34% below METHAZOLAMIDE 25 MG TABLET.
Who manufactures METHAZOLAMIDE 25 MG TABLET?
METHAZOLAMIDE 25 MG TABLET (NDC 68682002210) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.